Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, South Africa.
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, Cape Town, South Africa.
Dalton Trans. 2020 Aug 25;49(33):11543-11555. doi: 10.1039/d0dt01935f.
Iridium(iii) half-sandwich complexes containing 7-chloroquinoline-1,2,3-triazole hybrid ligands were synthesised and their inhibitory activities evaluated against the Plasmodium falciparum malaria parasite. Supporting computational analysis revealed that metal coordination to the quinoline nitrogen occurs first, forming a kinetic product that, upon heating over time, forms a more stable cyclometallated thermodynamic product. Single crystal X-ray diffraction confirmed the proposed molecular structures of both isolated kinetic and thermodynamic products. Complexation with iridium significantly enhances the in vitro activity of selected ligands against the chloroquine-sensitive (NF54) Plasmodium falciparum strain, with selected complexes being over one hundred times more active than their respective ligands. No cross-resistance was observed in the chloroquine-resistant (K1) strain. No cytotoxicity was observed for selected complexes tested against the mammalian Chinese Hamster Ovarian (CHO) cell line. In addition, speed-of-action assays and β-haematin inhibition studies were performed. Through preliminary qualitative and quantitative cell-free experiments, it was found that the two most active neutral, cyclometallated complexes can act as transfer hydrogenation catalysts, by reducing β-nicotinamide adenine dinucleotide (NAD+) to NADH in the presence of a hydrogen source, sodium formate.
合成了含 7-氯喹啉-1,2,3-三唑混合配体的铱(III)半夹心配合物,并评价了它们对恶性疟原虫疟原虫的抑制活性。支持性计算分析表明,金属首先与喹啉氮配位,形成动力学产物,该产物在加热一段时间后形成更稳定的环金属热力学产物。单晶 X 射线衍射证实了所分离的动力学和热力学产物的建议分子结构。铱的络合显著增强了所选配体对氯喹敏感(NF54)恶性疟原虫株的体外活性,与各自配体相比,所选配合物的活性提高了 100 多倍。在氯喹耐药(K1)株中未观察到交叉耐药性。在所测试的针对哺乳动物中国仓鼠卵巢(CHO)细胞系的选定复合物中未观察到细胞毒性。此外,还进行了作用速度测定和β-血红素抑制研究。通过初步的定性和定量无细胞实验,发现两种最活跃的中性、环金属化配合物可以作为转移氢化催化剂,在氢源甲酸钠存在下将β-烟酰胺腺嘌呤二核苷酸(NAD+)还原为 NADH。